A two-count declaratory judgment action for non-infringement of U.S. Patent Nos. 6,916,941 and 7,420,069, which are listed in the U.S. Food and Drug Administration’s Orange Book for Lexapro, filed by…
Infosint S.A.’s Irish patent has been revoked following a UK trial court ruling in a patent infringement suit it filed against Forest and H. Lundbeck A/S, a unit of Forest…
Hologic Inc. is defending itself against a patent infringement suit filed by Tissue Extraction Devices.
On May 10, 2011, Tissue Extraction Devices filed suit against Hologic and its subsidiary, Suros Surgical…
Patent infringement cases filed by Bayer Healthcare LLC against Abbott Laboratories relating to Humira(R} were settled during the second quarter of 2011.
In its 2010 Form 10-K, Abbott reported that lawsuits…
A trial on the two remaining patent claims in a suit filed by Conceptus Inc. against Hologic Inc. is scheduled to begin on Oct. 3, 2011.
On May 22, 2009, Conceptus…
A patent infringement suit filed by Abbott Laboratories against Lupin Pharmaceuticals and Lupin Limited relating to Niaspan(R) was settled and dismissed with prejudice during the second quarter of 2011.
In its…
Centocor Inc. has until Sept. 12, 2011 to ask the U.S. Supreme Court to review the Federal Circuit’s decision in a patent infringement suit it filed against Abbott Laboratories.
In April…
Abbott Laboratories obtained favorable ruling in a patent infringement suit filed by Medinol Limited.
In its Form 10-Q for the quarter ended March 31, 2011, Abbott reported that in March 2011…
Abbott Laboratories is seeking to enforce its patent rights relating to testosterone gel product, a drug that the Company sells under the trademark AndroGel(R).
In a case filed in the United…
Patent infringement suits filed by Abbott Laboratories against Impax Laboratories and Teva Pharmaceuticals USA Inc. relating to Tricor(R) were settled and dismissed with prejudice during the second quarter of 2011.
In…